V

VYGR

Voyager Therapeutics Inc

3.43

0.13+3.94%
After Hours: 3.430  0.00  0.00%19:57 05/19 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Assets

393.05M

351.28M

159.36M

193.85M

261.58M

Total Current Assets

276.81M

319.68M

124.50M

136.70M

197.77M

Total Non Current Assets

116.24M

31.60M

34.86M

57.16M

63.81M

Total Liabilities

93.29M

114.96M

100.34M

98.80M

107.26M

Total Current Liabilities

49.79M

64.51M

72.59M

50.98M

26.77M

Total Non Current Liabilities

43.50M

50.45M

27.75M

47.82M

80.50M

Total Equity

299.76M

236.32M

59.02M

95.06M

154.32M

Total Stockholders Equity

299.76M

236.32M

59.02M

95.06M

154.32M

Minority Interest

--

--

--

--

--

Total Liabilities & Shareholders Equity

393.05M

351.28M

159.36M

193.85M

261.58M

Total Common Shares Outstanding

54.73M

44.04M

38.61M

37.92M

37.37M

Total Preferred Shares Outstanding

--

--

--

--

--